1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin
(
- Contribution to journal › Article
-
Mark
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
(
- Contribution to journal › Article
- 2013
-
Mark
mTORC1 inhibition is required for sensitivity to PI3K p110α inhibitors in PIK3CA-mutant breast cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Chemosensitization of cancer cells by KU-0060648, a dual inhibitor of DNA-PK and PI-3K
(
- Contribution to journal › Article
- 2011
-
Mark
MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells
(
- Contribution to journal › Article
-
Mark
Global microRNA analysis of the NCI-60 cancer cell panel
(
- Contribution to journal › Article
-
Mark
Discovery of a novel B-Raf fusion protein related to c-Met drug resistance
(
- Contribution to journal › Article
- 1998
-
Mark
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer : the Nordic experience
1998) In Annals of oncology : official journal of the European Society for Medical Oncology 9(12). p.1301-1307(
- Contribution to journal › Article
- 1996
-
Mark
Multiple splicing variants of the estrogen receptor are present in individual human breast tumors
(
- Contribution to journal › Article